Trial Profile
An Observational study for long-term treatment with Denosumab in Osteoporotic women with resistance/intolerance to bisphosphonates
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jan 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
- 16 Jan 2017 New trial record